ReVIDA’s “Treatment for All” program provides comprehensive treatment services to eligible Tennesseans, without cost to them. This initiative is critical in removing barriers to care and creating ...

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds ...

Patients with opioid use disorder (OUD) had a lower risk of discontinuing methadone compared with buprenorphine/naloxone, and ...

New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people ...

Gov. Andy Beshear announced that Kentucky has received a $37.2 million, three-year federal grant from Substance Abuse and ...

Naltrexone (referred to as the "Ozempic of alcohol") is a drug that can help reduce alcohol and opioid cravings for people ...

Coupling short-acting opioids to reduce pain and misery with low-doses of buprenorphine, which mitigates cravings, has ...

Researchers analyzed 1.3 million health records and found Ozempic, Mounjaro could lower rates of drug and alcohol overdoses.

Receipt of methadone for opioid use disorder is associated with a lower risk for treatment discontinuation compared wi ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

In a new study examining people with opioid or alcohol use disorder, prescriptions for Ozempic, Wegovy, Mounjaro, and ...

Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating ...